Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DCD IIT: Evaluating the Safety of Utilizing Donor Hearts From Donation After Circulatory Death (DCD) Donors

NCT: NCT05462041 · ACTIVE_NOT_RECRUITING

NCT IDNCT05462041
StatusACTIVE_NOT_RECRUITING
Start Date2022-05-24
Completion2026-07-30
SponsorCedars-Sinai Medical Center (OTHER)
First posted
Last updated

Brief Summary

The purpose the research is to evaluate whether patients who receive a Donation after Circulatory Death (DCD) heart for cardiac transplantation using either normothermic regional perfusion (NRP) or direct procurement and perfusion (DPP) have similar outcomes as patients who receive Donation after Brain Death (DBD) heart using standard cold storage. The study will also evaluate whether DCD procured hearts have a meaningful impact on hearts available for transplantation at our center.

Frequently Asked Questions

What is DCD IIT: Evaluating the Safety of Utilizing Donor Hearts From Donation After Circulatory Death (DCD) Donors?

DCD IIT: Evaluating the Safety of Utilizing Donor Hearts From Donation After Circulatory Death (DCD) Donors is a clinical trial registered under NCT05462041. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05462041?

The current status of NCT05462041 (DCD IIT: Evaluating the Safety of Utilizing Donor Hearts From Donation After Circulatory Death (DCD) Donors) is: ACTIVE_NOT_RECRUITING.

When did DCD IIT: Evaluating the Safety of Utilizing Donor Hearts From Donation After Circulatory Death (DCD) Donors start?

DCD IIT: Evaluating the Safety of Utilizing Donor Hearts From Donation After Circulatory Death (DCD) Donors started on 2022-05-24.

Related Devices

K172609CSMC Cardiac SuiteCedars-Sinai Medical Center PMA P160013Normothermic machine perfusion system for the preservation of standard criteria donor lungs prior to transplantationTransMedics, Inc. PMA P200031Normothermic machine perfusion system for the preservation of donor livers prior to transplantationTransMedics, Inc. PMA P200035Normothermic machine perfusion system for the preservation of donor livers prior to transplantationOrganox Limited PMA P180014Normothermic preservation system for transplantation of initially unacceptable donor lungsXvivo Perfusion, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑